Around the world, new composites, nanomaterial (NM) products, and tailored nanoparticles (NPs) are constantly being developed. Due to its many applications in the rapidly expanding field of nanotechnology, the manufacturing of nanoparticles is growing. NPs can efficiently migrate to the circulatory system, cross the blood–brain barrier, and have cellular and molecular effects on organs and tissues. There is a need to assess the potentially harmful effects of nanomaterials on plants, animals, microbes, surroundings, and more that will be brought to light in the future. Studies using a variety of model organisms have revealed the potential adverse effects associated with its widespread use. Further in-depth understanding of the toxicity of NPs, potential absorption pathways, and the harmful consequences they may have on living things is still needed. This review investigates the possible pathways of NPs, their potential for toxicity, and the underlying mechanisms that give rise to these effects. Furthermore, the review highlights existing gaps in risk assessment frameworks and underscores the importance of implementing comprehensive risk management strategies tailored to nanoparticle composites. These strategies aim to mitigate potential adverse effects while maximizing the benefits of nanotechnology-enabled materials. Since this topic hasn't been examined in a while, the current laws and regulations set forth by regulatory bodies that define the primary principles and requirements for evaluating novel nanomaterials will also be covered.
The culture filtrate of Hypocrea lixii GGRK4 played a vital role as a reducing and stabilizing agent in the mycosynthesis of silver nanoparticles (AgNPs) using silver nitrate (AgNO3). The extracellular extract derived from fungi emerged as a noteworthy option for synthesizing AgNPs due to its potential composition of metabolites, including enzymes and other bioactive substances. Hence, the presence of a dark brown color serves as a key indicator for the biosynthesis of AgNPs through the reduction of Ag (I) ions to Ag by the fungal culture filtrate. To facilitate the synthesis of AgNPs, a combination of hybrid technologies, specifically the “one factor at a time” approach and statistical tools such as response surface methodology, was used using a face-centered central composite design (FCCCD). Utilizing a modified CX medium with pH of 5.02 supported the fungi synthesizing AgNPs at a temperature of 30°C. The multi-efficient AgNPs were characterized through various techniques, including UV–visible spectrophotometry, zeta size and potential analysis using a zeta size analyzer, transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), and fluorescence spectroscopy. The biosynthesized AgNPs have significant associated functional groups, revealed by FTIR analysis. TEM histogram analysis showed that these multi-efficient AgNPs have a size of 17.34 nm. Similarly, they have emission and excitation spectra of 450 nm and 390 nm, respectively, revealed by fluorescence spectrum analysis. Compared to the standard, the biosynthesized AgNPs have significant antibacterial and free radical scavenging properties and dye degradation capability. Additionally, the half-maximal inhibitory concentration (IC50) value was found statistically significant based on t-test analysis. Finally, the biosynthesized AgNPs could be used in potential applications encompassing ecofriendly degradation, antimicrobial activity, and therapeutic applications, such as free radical scavenging properties.